May 15 2009
Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the launch of a new research grant program, open to researchers from academic and non-profit institutions across North America.
"We are excited to offer this type of financial support to the research community at-large. Scientists are making ground-breaking discoveries in the field of microRNA research every day, with implications for human medicine in the form of new insights, new therapies and new diagnostics. Now, more than ever, we recommit ourselves to the success of our customers," says Erik Holmlin, Chief Commercial Officer, Exiqon A/S.
The Exiqon Grant Program has been established with an internal seed funding of $25,000, from which awards will be given to researchers to drive projects enhancing the understanding of how microRNA expression and function relates to normal cellular development, and/or disease-related cellular pathways.
Recipients may use Exiqon Grant Program awards for the purchase of any Exiqon microRNA product or service. Exiqon offers a complete product line for microRNA investigation, including products for RNA isolation, Microarray analysis, qRT-PCR analysis, Northern Blotting, In Situ Hybridization, and Knockdown studies. Exiqon also offers microRNA profiling services for both microarray and qRT-PCR analysis, complete with full sample QC and customized data analysis and reporting.
Researchers are invited to submit an abstract, outlining their research area, project goals, and proposed workflow no later than Monday, June 15th, 2009. Award conveyance through the Exiqon Grant Program does not influence, and is not influenced by, any other existing or potential sources of project funding.
Applications are due June 15th, 2009, and may be submitted electronically via a special Grant Program webpage, http://www.exiqon.com/ls/grants. Grant recipients will be announced no later than July 1st, 2009.